European agency rejects Serostim
BY Advocate.com Editors
May 01 2003 12:00 AM ET
The European Medicines Evaluations Agency on Monday announced that its scientific committee has rejected an application by Serono to market its anti-wasting drug Serostim to AIDS patients in Europe. The drug is approved for the treatment of AIDS-related wasting in the United States. In a statement, the agency said there was concern about the long-term safety of the medication and that long-term efficacy data also was lacking. Serostim is a recombinant human growth hormone that has been shown to increase muscle mass in those taking the medication.
- WATCH: Out Musician Mika Shares Video for 'Good Guys,' a Bittersweet Homage to Gay Men
- Vatican Official Calls Irish Marriage Vote 'Defeat for Humanity'
- Why Can't We Talk About Homophobia in the Black Community?
- PHOTOS: International Mr. Leather Weekend
- San Diego Mourns Third Trans Teen to Die by Suicide
- Dan Savage Calls Out Duggar's 'Staggering' Family Values Hypocrisy